Publications by authors named "Daryl E Morris"

Claim this Profile
S
Safety and immunogenicity of a polyvalent DNA-protein HIV vaccine with matched Env immunogens delivered as a prime-boost regimen or coadministered in HIV-uninfected adults in the USA (HVTN 124): a phase 1, placebo-controlled, double-blind randomised controlled trial.
Ian Frank, Shuying S Li, Nicole Grunenberg, Edgar T Overton, Samuel T Robinson, Daryl E Morris

Lancet HIV· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults.
Kristen W Cohen, Andrew Fiore-Gartland, Stephen R Walsh, Karina Yusim, Nicole Frahm, Daryl E Morris

J Clin Invest· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial.
Linda-Gail Bekker, Zoe Moodie, Nicole Grunenberg, Fatima Laher, Georgia D Tomaras, Daryl E Morris, Lynn Morris

Lancet HIV· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection.
Michael C Sneller, J Shawn Justement, Kathleen R Gittens, Mary E Petrone, Katherine E Clarridge, Daryl E Morris

Sci Transl Med· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection.
Susan Zolla-Pazner, Allan deCamp, Peter B Gilbert, Constance Williams, Nicole L Yates, Daryl E Morris

PLoS One· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial.
Susan Zolla-Pazner, Allan C deCamp, Timothy Cardozo, Nicos Karasavvas, Raphael Gottardo, Daryl E Morris

PLoS One· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contrasting two frameworks for ROC analysis of ordinal ratings.
Daryl E Morris, Margaret Sullivan Pepe, William E Barlow

Med Decis Making· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential of genes and other markers to inform about risk.
Margaret S Pepe, Jessie W Gu, Daryl E Morris

Cancer Epidemiol Biomarkers Prev· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of methods for oligonucleotide array data via quantitative real-time PCR.
Li-Xuan Qin, Richard P Beyer, Francesca N Hudson, Nancy J Linford, Daryl E Morris

BMC Bioinformatics· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis